Medical Imaging Challenges A lesser-known but clinically significant side effect of GLP-1 drugs is their impact on PET-CT scans
The FDA has approved tirzepatide under two brand names: Zepbound is used with a reduced-calorie diet and increased physical activity for long-term weight management in adults who have: A body mass index, or BMI, of 30 or higher A BMI of 27 or higher and at least one weight-related medical condition Zepbound is also approved for moderate-to-severe obstructive sleep apnea in adults with obesity
Specifically, the recovery of the general muscle weakness in the lithium-intoxicated rats, whatever the initial or end point, might be indicative of the counteraction of the lithium intoxication as whole [80]
J Med Genet (2013) 50(7):46372
Cuando los niveles de glucosa estn elevados, el GLP-1 promueve la secrecin de insulina en el pncreas, pero tiene un efecto mnimo cuando los niveles de glucosa son normales
While others battle sudden vomiting, bloating, diarrhea, or painful constipation, these symptoms usually peak during the increase in dose